Compounds > naringenin

naringenin and Carcinoma, Ovarian Epithelial

naringenin has been researched along with Carcinoma, Ovarian Epithelial in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Guo, Z; Li, H; Xu, J; Yuan, S1
Cao, D; Chen, H; Gao, Z; Lin, C; Lin, H; Lin, Y; Liu, H; Liu, SL; Luo, L; Luo, Y; Shi, Y; Wang, P; Wang, W; Xie, K; Yang, H; Yang, J; Zeng, Z; Zhao, Y1

Other Studies

2 other study(ies) available for naringenin and Carcinoma, Ovarian Epithelial

ArticleYear
BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.
    Molecular and cellular biochemistry, 2022, Volume: 477, Issue:5

    Topics: Apoptosis; bcl-X Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Flavanones; Humans; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction

2022
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 106

    Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; DNA, Ribosomal; ErbB Receptors; Female; Flavanones; Gastrointestinal Microbiome; Gentian Violet; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases

2022